$15.480
-0.079 (-0.51%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CGEM por análisis de gráficos similares
Alphio's CGEM stock price prediction model matches the current Cullinan Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.93 (-0.67%). The 1-week path is $15.27 (+1.58%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Cullinan Therapeutics Inc?
Cullinan Oncology Inc (CGEM) is a good buy right now, primarily driven by its current price of $14.37, which is significantly lower than analyst price targets of $35 to $47. The stock has shown a strong year-to-date change of +42.00% and a one-year change of +78.29%, suggesting positive momentum. However, the main risk is the negative earnings per share (EPS) forecast of -0.79 for the upcoming quarter, which could impact investor sentiment.
CGEM cerró en $15.48 el Thursday, tras bajar -0.51%
Cullinan Therapeutics Inc (CGEM) last closed at $15.0299997, losing -2.72%. These facts feed the 1-day and 1-week CGEM price prediction above.
Factores de la previsión
Los factores de la previsión de Cullinan Therapeutics Inc (CGEM) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CGEM, ordenadas por similitud.
Análisis de estacionalidad de CGEM
Historically the probability of a positive October return for CGEM is 66.18%. February offers the highest probability of a positive month at 67.24%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CGEM
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $7.88 | $8.95 | $10.56 | -40.45% |
| Nov 2026 | $6.16 | $6.72 | $6.72 | -55.29% |
| Dec 2026 | $7.28 | $7.72 | $8.69 | -48.65% |
En 2026, se proyecta que Cullinan Therapeutics Inc (CGEM) oscile entre $6.16 y $10.56.
Previsión mensual de Cullinan Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Cullinan Therapeutics Inc promedie $8.95, con un mínimo de $7.88 y un máximo de $10.56.
En Nov de 2026, se proyecta que Cullinan Therapeutics Inc promedie $6.72, con un mínimo de $6.16 y un máximo de $6.72.
En Dec de 2026, se proyecta que Cullinan Therapeutics Inc promedie $7.72, con un mínimo de $7.28 y un máximo de $8.69.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.